Dr. Hussain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7 Post Office Rd
Ste A
Waldorf, MD 20602Phone+1 301-893-0666Fax+1 301-893-1604
Education & Training
Howard UniversityResidency, Psychiatry, 1992 - 1995- Howard UniversityInternship, Transitional Year, 1991 - 1992
Gandhi Medical CollegeClass of 1974
Certifications & Licensure
MD State Medical License 1992 - 2026
DC State Medical License 1994 - 2024
VA State Medical License 1995 - 2004
Clinical Trials
- Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis Start of enrollment: 2018 May 01
- Cladribine Tablets After Treatment With Natalizumab (CLADRINA) Start of enrollment: 2020 Feb 19
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial Start of enrollment: 2022 Apr 01
Publications & Presentations
PubMed
- 4 citationsAcute relapse after initiation of Siponimod in a patient with secondary progressive MS.Rehana Z. Hussain, Shirley O’Leary, Fides M. Pacheco, Tresa Zacharias, Paul Litvak
Journal of Neurology. 2016-02-25 - 7 citationsA Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCRBenjamine Arellano, Rehana Z. Hussain, William A. Miller-Little, Emily Herndon, Doris Lambracht-Washington
Plos One. 2016-04-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
